Colace (docusate sodium) is not habit-forming. It does not create physical dependence, does not produce withdrawal symptoms when stopped, and does not require increasing doses to maintain an effect. The bigger concern with Colace, according to a growing body of clinical evidence, is that it may not work very well in the first place. Several hospitals have gone so far as to remove it from their formularies entirely, and gastroenterology guidelines have shifted toward recommending other options. Understanding why Colace holds such a peculiar position in medicine helps explain both its safety profile and the reasons you might want to reconsider relying on it long-term.
Why Colace Is Not Habit-Forming
Habit-forming drugs generally work by stimulating a receptor system or biochemical pathway in a way that the body adapts to over time, producing tolerance and dependence. Colace does not do this. It is a surfactant, meaning it lowers the surface tension of stool so that water and fats can penetrate it more easily. This action is purely physical and local. It does not stimulate the nerves that trigger bowel contractions, and it does not alter the brain’s reward pathways. There is no mechanism by which your body would “get used to” Colace and need more of it, nor would stopping it leave your bowels worse off than before you started.
This makes Colace fundamentally different from stimulant laxatives like bisacodyl or senna, which work by directly prodding the muscles of the intestinal wall into contracting. Even stimulant laxatives are less habit-forming than commonly feared, but Colace sits in an even milder category. Your colon does not become reliant on a surfactant the way it theoretically could with repeated nerve stimulation.
The Effectiveness Problem
If Colace is safe, why is it controversial? Because the evidence for its effectiveness is surprisingly thin. A randomized, double-blind, placebo-controlled trial in hospice patients found no significant differences between docusate and placebo in stool frequency, stool volume, stool consistency, or difficulty of evacuation when both groups also received senna. The study concluded there was no significant benefit of adding docusate to a stimulant laxative regimen.1PubMed. Randomized, double-blind, placebo-controlled trial of oral docusate in the management of constipation in hospice patients In other words, the patients who took Colace alongside senna did no better than those who took senna with a sugar pill.
A review of constipation management in long-term care settings reached a similar conclusion, noting that while stool softeners are the most commonly prescribed laxative category, they lack efficacy. The same review found that osmotic laxatives and psyllium (a bulk-forming fiber) had stronger evidence of actually working in older adults.2PubMed. Constipation in long-term care This gap between how widely Colace is prescribed and how little evidence supports it has become a significant topic in clinical pharmacy.
The disconnect is partly historical. Colace became a go-to recommendation decades ago, when the standards for proving a drug’s efficacy were less rigorous. It was cheap, available over the counter, and seemed harmless. Doctors and nurses adopted it almost reflexively for hospitalized patients, post-surgical patients, and anyone on opioids. By the time researchers ran rigorous trials, the habit of prescribing it was deeply embedded in medical culture.
Hospitals Are Dropping It
Some institutions have decided to act on the evidence. A structured de-implementation initiative at one hospital system successfully removed docusate from its inpatient formulary, concluding that docusate has no efficacy yet is widely prescribed and that a systematic strategy combining technology changes and multidisciplinary efforts could drive the change.3PubMed. Successful de-implementation of an ineffective practice: The fall of docusate This is not a fringe effort. Multiple pharmacy departments have published similar deprescribing projects, and pharmacist-led initiatives at hospitals across the United States and Canada have targeted docusate as a low-value medication that adds cost without clinical benefit.
For you as a consumer, this institutional shift is worth knowing about. If your doctor or pharmacist prescribed Colace years ago and you have been taking it since, the rationale behind that prescription may no longer hold up. That does not mean you need to panic or stop anything abruptly, but it does mean a conversation with your provider about whether something more effective would serve you better is warranted.
What Long-Term Safety Actually Looks Like
Setting aside the question of whether it works, Colace does have a reassuring safety profile. Side effects are mild and uncommon. The most frequently reported ones are stomach cramps, nausea, and throat irritation (particularly with the liquid form). Because the drug acts locally in the gut and has minimal systemic absorption, it does not accumulate in the body or affect organs the way medications absorbed into the bloodstream might.
There is one pharmacological wrinkle worth knowing about. Docusate sodium can potentially increase the absorption of other drugs taken at the same time, because its surfactant properties can alter how substances pass through the intestinal lining. A review in Drug Safety noted that docusate may potentiate the hepatotoxicity of other drugs, though reports of this are rare.4PubMed. Adverse effects of drugs used in the management of constipation and diarrhoea This is most relevant if you are taking medications that are hard on the liver, such as certain cholesterol drugs or high-dose acetaminophen. The risk is low, but it is the kind of interaction that matters more with long-term daily use than with occasional dosing.
As a practical precaution, spacing Colace apart from other medications by at least two hours reduces the chance of enhanced absorption. If you take multiple medications and are using Colace daily, mention it to your pharmacist so they can check for interactions you might not anticipate.
Colace During Pregnancy
Constipation during pregnancy is extremely common, driven by hormonal changes that slow gut motility plus the physical pressure of a growing uterus. Colace has long been one of the first recommendations for pregnant people, and the evidence supports its safety in this context. A review in Canadian Family Physician concluded that although few laxatives have been formally assessed for safety in pregnancy, they have minimal systemic absorption and are therefore not expected to be associated with an increased risk of congenital anomalies.5PubMed Central. Treating constipation during pregnancy
The catch is the same one that applies to every other use of Colace: it may not actually relieve your constipation. Many pregnant people find that increasing fiber intake, staying hydrated, and using an osmotic laxative like polyethylene glycol (MiraLAX) is more effective. Colace is not dangerous during pregnancy, but if it is not solving your problem, you are not obligated to keep taking it just because it was the first thing suggested.
Children and Colace
Pediatric constipation is another area where docusate gets prescribed despite limited supporting evidence. A study on docusate’s efficacy in children found no differences in adverse effects or acceptance between the treatment and comparison groups, which is reassuring on the safety front.6PubMed Central. Efficacy of docusate in the treatment of constipation in pediatric patients But the pattern holds: tolerability is not the same as effectiveness. Pediatric gastroenterology guidelines generally favor polyethylene glycol as a first-line treatment for childhood constipation because of its stronger evidence base.
Parents sometimes worry that any laxative will make their child’s bowels “lazy.” With Colace, this concern is misplaced because, again, it does not stimulate bowel contractions. It also does not appear to cause electrolyte imbalances or dehydration in children at standard doses. The risk with Colace in kids is not harm but wasted time, especially if a child is significantly backed up and needs something that will actually get things moving.
Laxative Abuse Is a Different Problem
When people ask whether Colace is habit-forming, they are sometimes conflating it with the broader issue of laxative abuse. Laxative abuse is a real clinical concern, but it almost always involves stimulant laxatives, not stool softeners. It occurs most frequently in people with eating disorders, where laxatives are misused as a purging method or, in some cases, as a form of self-harm.
Research into laxative abuse in eating disorder populations has found that it is associated with worse eating disorder psychopathology, higher rates of borderline personality features, and specific traits including suicidality and feelings of emptiness.7PubMed. Features associated with laxative abuse in individuals with eating disorders Other work has suggested that laxative abuse in these patients shares features with addiction, including novelty-seeking personality traits that are predictive of substance misuse.8PubMed Central. Personality characteristics and medical impact of stimulant laxative abuse in eating disorder patients—a pilot study A small study of a blinded laxative taper found that five of seven patients with eating disorders reduced their laxative intake by at least half, and three stopped entirely.9PubMed. A blinded laxative taper for patients with eating disorders
The critical point is that this body of research concerns stimulant laxatives, not docusate. Stool softeners like Colace do not produce the cramping, urgency, or dramatic fluid loss that stimulant laxatives cause, which is precisely what makes stimulant laxatives reinforcing in the context of purging behavior. Colace simply does not have the pharmacological profile to be abused in this way. If someone you know is taking large quantities of laxatives, the concern is valid, but Colace is unlikely to be the product involved.
What Works Better for Long-Term Constipation
If you have been using Colace for chronic constipation and are wondering whether to continue, the honest answer from the clinical evidence is that you can probably do better. Several alternatives have stronger evidence and are equally available over the counter.
- Polyethylene glycol (MiraLAX): An osmotic laxative that draws water into the colon. It has robust trial evidence across multiple populations, including older adults and children. Gastroenterology guidelines place it ahead of docusate.
- Psyllium (Metamucil): A bulk-forming fiber supplement that increases stool volume and moisture. The review of long-term care evidence found it effective for older adults.2PubMed. Constipation in long-term care It requires adequate water intake to work properly and can cause bloating if introduced too quickly.
- Magnesium-based osmotic laxatives: Products like milk of magnesia work similarly to polyethylene glycol by pulling water into the bowel. They are inexpensive and effective for occasional use, though people with kidney problems need to be cautious about magnesium accumulation.
- Stimulant laxatives (senna, bisacodyl): These are effective for more stubborn constipation. Despite the old myth that they damage the colon with long-term use, modern evidence suggests they are safer for extended use than previously believed. They are stronger than Colace and appropriate when gentler options have failed.
Switching from Colace to one of these options does not require a taper or transition period. You can simply stop taking Colace and start the alternative, since Colace does not produce rebound constipation or any withdrawal effect. If your constipation is persistent and not responsive to over-the-counter options, prescription medications exist that work through different mechanisms, and a gastroenterologist can help sort through them.
Why Colace Persists Despite Weak Evidence
Given all of this, it is reasonable to wonder why Colace remains one of the most widely sold stool softeners in the world. Part of the answer is sheer inertia. Generations of healthcare providers learned to recommend it, patients have used it for decades, and it occupies prime shelf space in every pharmacy. It is also genuinely harmless, which makes it easy to recommend without worrying about side effects. In medicine, “it probably won’t help, but it definitely won’t hurt” is a surprisingly powerful force.
Another factor is that some people do feel it helps them, even if clinical trials cannot distinguish its effect from placebo. Constipation is highly subjective, and the act of taking something, drinking extra water to swallow the pill, and paying attention to bowel habits can all contribute to improvement independent of the drug itself. There is nothing wrong with continuing Colace if you feel it works for you. The evidence just suggests that if it is not helping, there is no pharmacological reason to keep trying it in hopes that it will start working later.
The broader lesson from the Colace story is that “safe” and “effective” are two entirely separate questions. Colace answers the safety question convincingly: it is not habit-forming, it has minimal side effects, it does not damage the gut, and it is safe in pregnancy and in children. But safety alone does not make a drug worth taking every day. If you are managing chronic constipation, the conversation with your provider should focus on what actually moves the needle, not just what is least likely to cause a problem.